LONDON--(BUSINESS WIRE)--
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | UDG HEALTHCARE PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 08 July 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD |
|
|
||
Long |
Short |
||||
Number |
(%) |
Number |
(%) |
||
(1) |
Relevant securities |
|
|
|
|
4,581,248 |
1.82% |
359,906 |
0.14% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
227,643 |
0.09% |
2,766,236 |
1.10% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
| purchase/sell: | 0 |
0.00% |
0 |
0.00% |
|
|
|
|
|
||
| TOTAL: |
|
|
|
|
|
4,808,891 |
1.91% |
3,126,142 |
1.24% |
||
|
|
|
|
||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities |
Price per unit |
| Purchase | 344 |
10.7250 GBP |
| Purchase | 592 |
10.7300 GBP |
| Purchase | 1,170 |
10.7240 GBP |
| Purchase | 1,558 |
10.6802 GBP |
| Purchase | 1,561 |
10.6594 GBP |
| Purchase | 1,781 |
10.6882 GBP |
| Purchase | 1,848 |
10.6862 GBP |
| Purchase | 2,236 |
10.7200 GBP |
| Purchase | 2,241 |
10.7048 GBP |
| Purchase | 3,120 |
10.7183 GBP |
| Purchase | 3,679 |
10.7109 GBP |
| Purchase | 3,770 |
10.7100 GBP |
| Purchase | 17,774 |
10.7090 GBP |
| Purchase | 24,027 |
10.7153 GBP |
| Purchase | 26,933 |
10.7489 GBP |
| Purchase | 250,000 |
10.7000 GBP |
| Purchase | 657,150 |
10.6950 GBP |
| Sale | 566 |
10.5550 GBP |
| Sale | 581 |
10.7200 GBP |
| Sale | 880 |
10.7122 GBP |
| Sale | 992 |
10.7505 GBP |
| Sale | 1,334 |
10.7150 GBP |
| Sale | 2,747 |
10.7083 GBP |
| Sale | 5,500 |
10.7109 GBP |
| Sale | 7,195 |
10.7086 GBP |
| Sale | 12,179 |
10.7100 GBP |
| Sale | 63,889 |
10.7273 GBP |
| Sale | 1,376,740 |
10.7014 GBP |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction | Number of relevant securities |
Price per |
|
unit | ||
| SWAP | Long | 17,505 |
10.7500 GBP |
| SWAP | Long | 19,944 |
10.7309 GBP |
| SWAP | Long | 37,262 |
10.7093 GBP |
| SWAP | Short | 300 |
10.7100 GBP |
| SWAP | Short | 3,329 |
10.7000 GBP |
| SWAP | Short | 9,700 |
10.6676 GBP |
| SWAP | Short | 9,923 |
10.7505 GBP |
| SWAP | Short | 19,214 |
10.7121 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 9 Jul 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |